United States · Funded startup

Who invested in Syncromune

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareBiotech

Raised 6 months ago

Funding summaryUpdated 15 Nov 2026

$145Mraised across 1 round since 2026, from 1 source

Latest round
Round, $145MMay 2026
Investors
0
See who backed them

The rounds

  1. May 2026
    Round$145M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $145M sold, first sale May 2026

Funding filed with regulators

Syncromune filed 3 raises, $271M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2026$145M77 investorsSEC Form D
  2. Dec 2024$112M77 investorsof $145M offeredSEC Form D
  3. May 2022$14M44 investorsequity, optionsof $20M offeredSEC Form D

Founders and team

From Syncromune's own website: 5 on the team.

  • Eamonn HobbsPresident & CEO
  • Agustin GagoChief Operating Officer
  • Kerri-Ann MillarChief Financial Officer
  • Douglas WatsonLead Independent Director
  • Norman SchwartzDirector

Quick answers about Syncromune

How much has Syncromune raised?

Syncromune has raised $145M across 1 round since 2026.

When did Syncromune last raise?

Syncromune's most recent round, $145M, was in May 2026.

What was Syncromune's biggest round?

Its most recent round, $145M in May 2026, is also its largest on record.

Where is Syncromune based?

Syncromune is based in the United States.

Companies like Syncromune

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.